Day 30: The AI Set Another High. The Gap Shrank — Because the Index Fell, Not Because It Won. (August 2026)

I am not a licensed financial advisor. This is a documented public experiment, not investment advice. Every trade, every hold, and every dollar amount is logged and publicly verifiable. See the pre-registration post for the full rules of this experiment.

This is Day 30 of the Investing Smarter Test — a 12-month experiment where I gave an AI $1,000 in a real Robinhood account and let it trade on its own. The only question I’m trying to answer: can an AI beat the simplest thing a person could do with $1,000, which is drop it in an S&P 500 index fund and walk away?

This morning the market handed the AI four separate stories with real momentum behind them — a copper-miner fund riding a four-year-high manufacturing report, a silver-miner fund near a seven-week high, a gold fund bouncing off its own base, and a biotech stock with a dated FDA catalyst. The AI researched all four in full and passed on every one. It also touched a new account-value high today. And the gap to the index got smaller. Here’s the part that matters: it got smaller because the index had a red day, not because the AI did anything differently. Both things — the new high and the honest reason the gap narrowed — are true at once.

Here’s where things stand.

Quick plain-English note, in case you’re newer to this: when I say the S&P 500 (ticker SPY), I just mean a single investment that holds a slice of America’s 500 biggest companies all at once — Apple, Microsoft, your bank, the company that makes your toothpaste. You buy one thing and you instantly own a little piece of all of them. That’s the “boring index fund” everyone keeps telling you to buy — and it’s the yardstick the AI has to beat. Learn that one term and you’re already ahead of most people.

What This Does Not Prove

Before I show you the scoreboard, a word about what you’re looking at.

This is one account. One run. One AI. Twelve months. A $1,000 account doesn’t have enough room to truly blow up — and it doesn’t have enough room to meaningfully beat the market either. Statistics require sample sizes. One experiment is a story, not a proof.

If the AI is up right now, that doesn’t prove AI investing works. If it’s down, that doesn’t prove it can’t. What it does prove is whether this specific AI, following this specific strategy, beat or lost to the simplest available alternative — a plain index fund — over this particular stretch of time.

I’m publishing every day, win or lose. If the AI blows up, you’ll see it here. That’s the point.

The Investing Smarter Test Scoreboard — Day 30 (August 6, 2026)

The S&P 500 benchmark: $1,000 invested in SPY on June 22, 2026, dividends reinvested, no fees (no dividends have come due since then, so today’s figure is price return only). The honest comparison is always “what would $1,000 in an index fund have done?” Quote timestamp for today’s figures: 2026-08-06T18:38:13Z — an intraday snapshot taken while the regular session was open, not a closing print. SPY’s last trade at that moment was $768.995, down from Wednesday’s close of $769.79 — the index itself was having a red day when this scoreboard was captured.

One more plain-English term, since it’s in the table: max drawdown just means the biggest drop from a high point to a low point along the way — the worst dip you’d have had to sit through. A small max drawdown means a smoother, less stomach-churning ride; a big one means it fell hard at some point before recovering. It’s a simple way to measure not just how much you made, but how bumpy the road was to get there.

The AI account is at $1,017.21, up $17.21 from its $1,000 start — a new dollar-value high for the account, edging past the previous $1,014.03 peak set just yesterday on Day 29. The S&P 500 twin is at $1,033.22, up $33.22. That leaves the AI behind by $16.01 — narrower than yesterday’s $22.73, which was the widest gap of the experiment so far. Here’s the honest reason it narrowed: SPY itself fell today, from $769.79 to $768.995, so the twin’s own value barely moved while the AI’s three holdings ground out modest gains — the gap closed because the index had a bad day, not because the AI did anything smarter than yesterday. Roughly 56% of the account is still sitting in cash, exactly as it was yesterday and the day before; nothing was bought or sold. I’d give this same caution whether the AI were ahead or behind, and whether the gap were widening or narrowing: this is a tiny account over a short stretch, and a move like today’s is closer to noise than a verdict. It has swung by double digits within the last week alone and could swing again just as easily, in either direction.

If This Were $10,000 Instead of $1,000

I started this with $1,000 because that’s a real, relatable amount and it’s what I was willing to hand an AI. But a lot of you are thinking about more than that — so here’s the same result scaled up. Same trades, same percentages, just 10× the starting money:

The point of showing both isn’t “look what the AI could have made you.” It’s the gap. At $1,000 the AI is behind the boring index fund by $16.01; scaled to $10,000 that same gap is $160.15 — same story, bigger numbers. Whether it’s $1,000 or $10,000 or $100,000, the question is identical: did the clever thing beat the boring index fund? Right now, on this particular day, the honest answer is still no — even on a day the gap happened to get smaller. (This is illustrative scaling of an already-tiny sample — not a projection, not a promise. Past performance is not future performance.)

Why the AI Held — And Why That’s the Whole Point

Here’s the thing nobody tells you about investing: most of the skill is in not doing things.

Today wasn’t a quiet day to sit on your hands — it was a loud one. The AI’s discovery process turned up four names with real, checkable stories behind them: a copper-miner fund up 9.3% in three sessions on a four-year-high manufacturing report, a silver-miner fund up 17.4% off a recent low as silver itself neared a seven-week high, a gold fund bouncing off its own multi-week base, and a biotech stock with FDA meetings dated for later this year. Four separate “don’t miss this” headlines in a single morning. A human staring at that lineup feels the itch to grab at least one of them. The AI grabbed none.

At the open this morning it screened a 1,895-name universe (1,590 stocks and 305 ETFs), drew a 40-name dated slate across 12 sector and size clusters, and triaged out 36 of those 40 before anyone had to form an opinion about them: 13 on a hard liquidity rule (the gap between buy and sell price was too wide), 6 as duplicate or out-of-scope instruments (a second gold fund, a second emerging-markets fund it already owns through VWO, three bond or cash-equivalent funds, and one broad U.S.-market fund), 1 that was simply outside today’s research budget, and 16 more dropped by an automatic safety check for an incomplete regulatory filing review or a separate liquidity fail. That left exactly 4 real finalists — a copper-miner ETF (COPX), a silver-miner ETF (SIL), a gold fund (IAU), and a biotech stock (OCUL) — and the AI researched all four in full. It passed on every one. Here’s the reasoning it logged, condensed from the full record for length (nothing has been reworded, only trimmed):

“FUNNEL, HONESTLY STATED: discovery ran a 1,895-name universe (1,590 stocks + 305 ETFs) down to a 40-name date-seeded slate across 12 clusters. It triaged out 36 before deep research: 13 on the quoted-spread fence alone … 6 on instrument-class/duplication grounds … 1 (DEM) purely on the 20-slot cap, and 16 more … on an incomplete mandatory EDGAR check or a liquidity fail. That left 4 finalists deep-researched, and I personally evaluated all four — OCUL, COPX, SIL, IAU — and I pass on every one.

SIL is out on the fence, not on judgment: 30d ADV 939,579 shares vs the 2,000,000-share floor in rule 10; the spread passes at 0.143% but the volume test does not, and I do not relax a fence for a setup I like the look of.

OCUL is a catalyst-only case with everything else pointing the wrong way: TTM net margin -579.1% and deteriorating, TTM revenue -8.1% y/y, a $301.4M TTM loss on $52.1M of revenue, price below both a falling 50-day and 200-day average, an active securities class action from a February 2026 trial-data disclosure, and a stated cash runway that excludes the very drug-launch costs it would need to cover — i.e. live dilution risk. Decisively: this name has gapped -21% and +28% in single sessions on regulatory news within eight months, so my own -15% backstop cannot actually protect the position; a stop I know can be jumped is not a stop, and I will not pretend otherwise to take a binary bet.

COPX I like structurally — the 50-day average is above the 200-day, price is above both, and July ISM Manufacturing at 55.6% is a real checkable macro datum, not a story — but the entry is the problem: +9.3% in three sessions into a known resistance band, and two named Wall Street houses forecast copper BELOW the price this basket is discounting, with miners geared to the downside of that. A -31.5% six-month drawdown in this fund tells me what happens when copper mean-reverts. Buying a three-day thrust because it is going up is the momentum-story sourcing I am not allowed to use, and I have no independent reason to pay this level today.

IAU fails a simpler test: the 50-day average sits well below the 200-day, so this is a bounce inside an intact downtrend; YTD NAV total return is -5.34% against SPY roughly +7%, with sizable net outflows over the trailing month, no cash flow, and a 0.25% sponsor fee carried against the interest my cash is currently earning. That is a coin-flip on the dollar, not an edge.

NOW THE HOLDINGS — a fresh call on each, not a default. BRK.B: neither kill criterion has fired — price is 10% above the kill level and the thesis is CONFIRMING. I considered adding, and declined: I have no fresh Berkshire-specific data this tick, and ‘it went up’ is explicitly not a reason to add. HOLD. XBI: an add is permitted here and it is the one I weighed hardest — but an add requires an entry-quality reason on TODAY’s data, and today’s dossier contains no fresh biotech-sector evidence at all. Adding on a quote alone would be exactly the unexamined-momentum reasoning I rejected in COPX, and I will not apply a looser standard to a name simply because I already own it. HOLD, no add. VWO: small loss, thesis STILL DEVELOPING, no averaging down and none contemplated. HOLD.

So: three holdings worth roughly $445 (about 44% of the book) all kept on stated merits, roughly $555 in interest-earning settled cash, and no new position, because on this slate the only two names with a real setup are either extended into a forecast headwind (COPX) or below their own long-term average (IAU), and the two with a story attached fail the fence outright (OCUL’s un-stoppable gap risk, SIL’s trading-volume floor). Cash is a position today, not a failure to find one.”

A note on reading that: the AI will always write a confident explanation. Confident reasoning is not the same as correct reasoning. I’m logging it exactly as written (trimmed only for length, never reworded) so we can look back later and see whether it was right — or whether it just sounded right.

What holding means for the strategy:

This is a buy-and-hold experiment. Most days should be hold days. The AI is not supposed to be trading constantly — constant trading generates fees and taxes, which is one of the ways active strategies underperform indexes over time. So today’s hold is the expected behavior, not a cop-out.

The copper story is worth pulling out on its own, because it’s the one the AI itself said it “liked structurally.” A four-year high in a manufacturing survey is a real, checkable macro fact — not a rumor or a headline someone made up — and the fund’s own trend lines pointed the right way. But the AI still passed, because two separate Wall Street research desks were forecasting the underlying commodity price to fall well below where it’s currently trading, and a fund that’s already run 9.3% in three days into a known resistance zone was, in the AI’s words, a “three-day thrust,” not a fresh opportunity. Liking the macro story and liking the entry price turned out to be two different questions, and the AI answered them separately instead of letting the exciting one carry the other.

The biotech name is worth a word too, because it’s the most emotionally loaded of the four. A stock with a specific, dated FDA catalyst later this year is exactly the kind of story that shows up as “BREAKING” on a financial news app — and the AI’s own research laid out real reasons for optimism sitting right alongside the reasons against. What settled it wasn’t the catalyst itself; it was the fact that this particular stock has already gapped more than 20% in a single session, in both directions, on regulatory news within the past eight months. A safety net that can be jumped that easily isn’t really a safety net, and the AI said so plainly rather than pretending its own risk controls would hold.

And then there’s the honest math behind today’s headline number. The gap between the AI and the index got smaller today — from $22.73 yesterday down to $16.01 — and it would be easy to read that as the AI clawing back ground. It didn’t. SPY itself dropped, from $769.79 to $768.995, on a day the AI’s own three holdings happened to be up a little. When the thing you’re racing against stumbles, the distance between you shrinks even if you didn’t speed up. I’ll keep saying that plainly every time it’s true, in both directions — it’s the same discipline that says a widening gap isn’t a verdict either.

What You Should Actually Do With $1,000

I get this question every time I write about investing experiments: “Should I do what the AI is doing?”

Here’s my honest answer: probably not.

If you have $1,000 to invest and you don’t know what to do with it, the research is clear. Put it in a low-cost S&P 500 index fund — something like SPY, VOO, or FSKAX. Set it up as automatic monthly contributions if you can. Don’t check it daily.

Where to actually do it. For each service I’m showing you two links: a referral link (we both get a small bonus or free money if you sign up through it) and a plain direct link (I get nothing). Your choice, never required. I explain my full policy on referral links on my editorial independence page.

• Vanguard — the low-cost gold standard. Buy VOO directly; ~0.03%/yr. Best if you want the cheapest DIY option. No referral program → one link only: vanguard.com.
• Betterment — robo-advisor that auto-builds and rebalances an index portfolio (~0.25%/yr). → referral link (we both get a bonus) or plain link (I get nothing).
• Acorns — rounds up spare change and invests it; best for building the habit. → referral link ($5 for you after you invest) or plain link (I get nothing).
• Robinhood — the commission-free broker this experiment itself runs on; fine for buying VOO/SPY and leaving it alone. → referral link (free fractional share, $5–$200 value, for both of us) or plain link (I get nothing).

That’s it. That’s the boring, reliable thing. The entire point of this experiment is to find out whether a sophisticated AI can actually beat that boring, reliable thing — and after 30 days, here’s exactly where it stands: the AI is $16.01 behind the index fund.

Before I gave the AI a dollar, I laid out the whole case for why this is a genuinely hard thing to do — the pre-registration post I wrote before it started. I made my reasoning public on day zero so nobody could accuse me of writing the ending afterward. Whether the AI proves me right or surprises me, you’ll see it happen in real time — that’s the fun of it.

And if you’re carrying debt alongside any investing impulse, worth a read: the research on whether to invest or pay off debt first. The answer is more nuanced than most financial advice acknowledges.

Transparency: The Full Log Is Public

Every trade this AI has made or declined to make — plus its logged reasoning — is publicly documented. The entire series is archived in the Investing and Savings category, and each post links to the one before it. If you want to read the complete day-by-day record, start with the pre-registration post and follow the chain. The last published entry before this one is Day 29, the day the AI’s own dollar high coincided with the widest gap of the experiment so far.

That’s the deal I made with readers before this experiment started, and I’m keeping it.

Frequently Asked Questions

Q: How is the S&P 500 benchmark calculated?
A: I recorded the price of SPY (the SPDR S&P 500 ETF Trust) on June 22, 2026, the same day the AI account started. The benchmark tracks what $1,000 invested in SPY that day — with dividends reinvested and no fees — would be worth today. It’s the simplest honest comparison: what would doing nothing have gotten you?

Q: The AI hit a new high and the gap to the index also got smaller. Isn’t that good news?
A: It’s a real new high — $1,017.21 tops the previous $1,014.03 record set on Day 29 — but the narrower gap isn’t a sign the AI did anything differently today. SPY itself fell, from $769.79 to $768.995, so the index’s own dollar value barely grew while the AI’s existing holdings ground out modest gains. The gap shrank from $22.73 to $16.01 because the thing it’s racing against had a red day, not because the AI made a smarter move. It still hasn’t bought anything new, and roughly 56% of the account remains in cash.

Q: Why did the AI research four different names today and still pass on all of them?
A: A copper-miner fund (COPX), a silver-miner fund (SIL), a gold fund (IAU), and a biotech stock (OCUL) all survived the AI’s triage process and got full research. COPX had a genuinely strong macro backdrop but was priced ahead of where two Wall Street forecasters expect the underlying commodity to go. SIL failed a straightforward trading-volume rule despite an otherwise-tradable price. IAU is still in a longer-term downtrend beneath its own 200-day average despite today’s bounce. OCUL had a real dated catalyst, but a documented history of 20%-plus single-session price gaps that would blow through the AI’s own stop-loss rule. Four real stories, four separate reasons to walk away — none of them a coin flip the AI was willing to take.

Coming Up

Every weekday morning I post what the AI decided and where the scoreboard stands. The boring truth is most days the answer will be “it held, and holding was right.” Come watch whether the clever machine can actually beat the index fund you could set up in ten minutes and forget. Browse the full series here so you don’t miss the day the experiment proves its point — in either direction.

This is what I’m seeing after over 30 years of helping people with money and debt. This experiment is a transparent public test — not a recommendation. Only you know your full financial situation. Take this as input for your thinking, not a directive. Nobody gets to tell you what to do with your money. Not me, not anyone.

Steve Rhode The Get Out of Debt Guy | Consumer Debt Expert

Consumer debt expert & investigative writer. Personal bankruptcy survivor (1990). Washington Post award-winning author. Exposing debt scams since 1994.

See Full Bio

How to Get out of Debt Money Troubles Money Personalities Budgeting Behavioral Economics Motivation Inspiration Money Management The History of Credit and Debt Getting Out of Debt Get Out of Debt Debt Settlement Credit Counseling Loan & Debt Relief Scams Debt Relief Industry Practices Exposing Deceptive Financial Services Helping Consumers Navigate Financial Hardship Consumer Advocacy Consumer Debt Expert Consumer Protection Debt Relief Scam Student Loan Bankruptcy Debt Validation Debt and Mental Health Student Loans Debt Consolidation Debt in the Military Bankruptcy Consumer Debt Credit Card Debt Debt Relief Scams Personal Finance YMYL Financial Content Chapter 7 Bankruptcy Chapter 13 Bankruptcy Medical Debt Student Loan Debt Consumer Bankruptcy Financial Fraud Exposure Collections Investigative Writing Fraud investigation True Crime Research